Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects

por Zanchi, Anne, Pruijm, Menno, Muller, Marie-Eve, Ghajarzadeh-Wurzner, Arlène, Maillard, Marc, Dufour, Nathalie, Bonny, Olivier, Wuerzner, Grégoire, Burnier, Michel
Publicado 2022

Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Tr...

por Zanchi, Anne, Burnier, Michel, Muller, Marie‐Eve, Ghajarzadeh‐Wurzner, Arlène, Maillard, Marc, Loncle, Nicolas, Milani, Bastien, Dufour, Nathalie, Bonny, Olivier, Pruijm, Menno
Publicado 2020

Smartphone based blood pressure measurement: accuracy of the OptiBP mobile application according to the AAMI/ESH/ISO universal validation protocol

por Degott, Jean, Ghajarzadeh-Wurzner, Arlene, Hofmann, Gregory, Proença, Martin, Bonnier, Guillaume, Lemkaddem, Alia, Lemay, Mathieu, Christen, Urvan, Knebel, Jean-François, Durgnat, Virginie, Burnier, Michel, Wuerzner, Gregoire, Schoettker, Patrick
Publicado 2021